Cost-effectiveness analysis of oral antiviral therapy in patients with indeterminate chronic hepatitis B infection. [PDF]
Zhuo HY +5 more
europepmc +1 more source
Clinical phases and classification of breast tumor dormancy. Tumor dormancy is described as the period after treatment until residual tumor cells become detectable as relapsing disease in clinic. During the period of clinical tumor dormancy, tumor mass dormancy and cellular dormancy may coexist.
Shu Chen +4 more
wiley +1 more source
The application and prospects of antimicrobial peptides in antiviral therapy. [PDF]
Yang F, Ma Y.
europepmc +1 more source
This illustration integrates key concepts covered in the review, including high‐risk populations, viral structure, host entry factors, the replication cycle, and licensed antibody‐based prevention strategies. ABSTRACT Respiratory syncytial virus (RSV) is a negative‐sense RNA virus belonging to the genus Orthopneumovirus within the family Pneumoviridae.
Zekai Cheng +3 more
wiley +1 more source
Phyto-derived interferons: a promising frontier in antiviral therapy development. [PDF]
Venkidasamy B +2 more
europepmc +1 more source
Overcoming Cytomegalovirus Induced Immune Thrombocytopenia in Immunocompetent Adults - A Case of Antiviral Therapy Efficacy. [PDF]
Baddam S, Thiriveedi M, Patel S.
europepmc +1 more source
Magnesium Oxide Nanoparticles: A New Frontier in Antiviral Therapy Against Herpes Simplex Virus Type 1. [PDF]
Jwaziri AK +5 more
europepmc +1 more source
Cytomegalovirus Corneal Endotheliitis Presenting As Bullous Keratopathy: Resolution With Antiviral Therapy Alone. [PDF]
Sakamoto K +3 more
europepmc +1 more source
Protective Effects of Recombinant Zoster Vaccine and Antiviral Therapy Against Cardiovascular Disease Following Herpes Zoster Infection. [PDF]
Xu X +4 more
europepmc +1 more source
Mother-to-child transmission of hepatitis B virus, its associated risk factors, and the adoption of maternal antiviral therapy in eastern China: a retrospective cohort study. [PDF]
Sun M, Chen X, Chen Y, Zhang X.
europepmc +1 more source

